Cargando…

Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii

Correction for ‘Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii’ by Sajal Kumar Halder et al., RSC Adv., 2022, 12, 24319–24338, https://doi.org/10.1039/D2RA02939A.

Detalles Bibliográficos
Autores principales: Halder, Sajal Kumar, Mim, Maria Mulla, Alif, Md. Meharab Hassan, Shathi, Jannatul Fardous, Alam, Md. Nuhu, Shil, Aparna, Himel, Mahbubul Kabir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465633/
https://www.ncbi.nlm.nih.gov/pubmed/36199598
http://dx.doi.org/10.1039/d2ra90089k
_version_ 1784787842209153024
author Halder, Sajal Kumar
Mim, Maria Mulla
Alif, Md. Meharab Hassan
Shathi, Jannatul Fardous
Alam, Md. Nuhu
Shil, Aparna
Himel, Mahbubul Kabir
author_facet Halder, Sajal Kumar
Mim, Maria Mulla
Alif, Md. Meharab Hassan
Shathi, Jannatul Fardous
Alam, Md. Nuhu
Shil, Aparna
Himel, Mahbubul Kabir
author_sort Halder, Sajal Kumar
collection PubMed
description Correction for ‘Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii’ by Sajal Kumar Halder et al., RSC Adv., 2022, 12, 24319–24338, https://doi.org/10.1039/D2RA02939A.
format Online
Article
Text
id pubmed-9465633
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-94656332022-10-04 Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii Halder, Sajal Kumar Mim, Maria Mulla Alif, Md. Meharab Hassan Shathi, Jannatul Fardous Alam, Md. Nuhu Shil, Aparna Himel, Mahbubul Kabir RSC Adv Chemistry Correction for ‘Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii’ by Sajal Kumar Halder et al., RSC Adv., 2022, 12, 24319–24338, https://doi.org/10.1039/D2RA02939A. The Royal Society of Chemistry 2022-09-12 /pmc/articles/PMC9465633/ /pubmed/36199598 http://dx.doi.org/10.1039/d2ra90089k Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Halder, Sajal Kumar
Mim, Maria Mulla
Alif, Md. Meharab Hassan
Shathi, Jannatul Fardous
Alam, Md. Nuhu
Shil, Aparna
Himel, Mahbubul Kabir
Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_full Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_fullStr Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_full_unstemmed Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_short Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_sort correction: oxa-376 and oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of acinetobacter baumannii
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465633/
https://www.ncbi.nlm.nih.gov/pubmed/36199598
http://dx.doi.org/10.1039/d2ra90089k
work_keys_str_mv AT haldersajalkumar correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT mimmariamulla correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT alifmdmeharabhassan correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT shathijannatulfardous correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT alammdnuhu correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT shilaparna correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT himelmahbubulkabir correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii